Intra-articular Microparticles for Drug Delivery to the TMJ

Abstract

This study describes the in vivo biocompatibility of intra-articular poly(DL-lactic-co-glycolic acid) (PLGA) microparticle (MP) formulations in the rat temporomandibular joint (TMJ). To our knowledge, this is the first intra-articular microparticle-based drug delivery system for the TMJ. The impact of PLGA MP concentration on rat TMJ function was quantified via computerized meal pattern analysis; in this non-invasive technique, previously validated markers of TMJ pain or nociception (specifically, meal duration and food intake) were recorded by computer-monitored pellet feeders. Bilateral intra-articular injection of 15, 30, or 50 mg/mL PLGA MPs had no impact on meal duration or food intake over 6 days, compared with controls that did not receive injections. Histological analysis showed that the MPs were retained within the synovial lining. These findings indicate that the PLGA MPs described herein are biocompatible and suitable for intra-articular delivery to the rat TMJ, a finding that has significant implications for the improvement of TMJ therapeutics.

Keywords

temporomandibular joint temporomandibular disorder intra-articular drug delivery microparticle

Get full access to this article

View all access options for this article.

References

Bellinger

Spears

King

Dahm

Hutchins

Kerins

. (2007). Capsaicin sensitive neurons role in the inflamed TMJ acute nociceptive response of female and male rats. Physiol Behav 90:782-789.

Butoescu

Jordan

Doelker

(2009a). Intra-articular drug delivery systems for the treatment of rheumatic diseases: a review of the factors influencing their performance. Eur J Pharm Biopharm 73:205-218.

Butoescu

Seemayer

Palmer

Guerne

Gabay

Doelker

. (2009b). Magnetically retainable microparticles for drug delivery to the joint: efficacy studies in an antigen-induced arthritis model in mice. Arthritis Res Ther 11:R72.

Cleek

Ting

Eskin

Mikos

(1997). Microparticles of poly(DL-lactic-co-glycolic acid)/poly(ethylene glycol) blends for controlled drug delivery. J Control Release 48:259-268.

Ekuni

Firth

Putnins

(2006). RNA integrity and in situ RT-PCR in dento-alveolar tissues after microwave accelerated demineralisation. Arch Oral Biol 51:164-169.

Harper

Kerins

Talwar

Spears

Hutchins

Carlson

. (2000). Meal pattern analysis in response to temporomandibular joint inflammation in the rat. J Dent Res 79:1704-1711.

Hedberg

Shih

Solchaga

Caplan

Mikos

(2004). Controlled release of hyaluronan oligomers from biodegradable polymeric microparticle carriers. J Control Release 100:257-266.

Herring

(2003). TMJ anatomy and animal models. J Musculoskelet Neuronal Interact 3:391-394.

Horisawa

Kubota

Tuboi

Sato

Yamamoto

Takeuchi

. (2002). Size-dependency of DL-lactide/glycolide copolymer particulates for intra-articular delivery system on phagocytosis in rat synovium. Pharm Res 19:132-139.

10.

Kerins

Carlson

McIntosh

Bellinger

(2003). Meal pattern changes associated with temporomandibular joint inflammation/pain in rats; analgesic effects. Pharmacol Biochem Behav 75:181-189.

11.

Kerins

Carlson

McIntosh

Bellinger

(2004). A role for cyclooxygenase II inhibitors in modulating temporomandibular joint inflammation from a meal pattern analysis perspective. J Oral Maxillofac Surg 62:989-995.

12.

Kerins

Carlson

Hinton

Hutchins

Grogan

Marr

. (2005). Specificity of meal pattern analysis as an animal model of determining temporomandibular joint inflammation/pain. Int J Oral Maxillofac Surg 34:425-431.

13.

Liggins

Cruz

Min

Liang

Hunter

Burt

(2004). Intra-articular treatment of arthritis with microsphere formulations of paclitaxel: biocompatibility and efficacy determinations in rabbits. Inflamm Res 53:363-372.

14.

Mercuri

Giobbie-Hurder

(2004). Long-term outcomes after total alloplastic temporomandibular joint reconstruction following exposure to failed materials. J Oral Maxillofac Surg 62:1088-1096.

15.

Mountziaris

Kramer

Mikos

(2009). Emerging intra-articular drug delivery systems for the temporomandibular joint. Methods 47:134-140.

16.

National Institute of Dental and Craniofacial Research (NIDCR) (2008). Data & statistics. Bethesda, MD: National Institutes of Health.

17.

Nishide

Kamei

Takakura

Tamai

Tabata

Ikada

(1999). Fate of biodegradable DL-lactic acid oligomer microspheres in the articulus. J Bioact Compat Polym 14:385-398.

18.

Patel

Yamamoto

Ueda

Tabata

Mikos

(2008). Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2. Acta Biomater 4:1126-1138.

19.

Polysorbate 80 (2009). Inactive ingredient search for approved drug products. Rockville, MD: United States Food and Drug Administration. http://google2.fda.gov/search?q=polysorbate+80&client=FDAgov&site=FDAgov&lr=&proxystylesheet=FDAgov&output=xml_no_dtd&getfields=*&x=11&y=12 (URL accessed 5/4/2010).

20.

Tanaka

Detamore

Mercuri

(2008). Degenerative disorders of the temporomandibular joint: etiology, diagnosis, and treatment. J Dent Res 87:296-307.

21.

Tuncay

Calis

Kas

Ercan

Peksoy

Hincal

(2000). Diclofenac sodium incorporated PLGA (50:50) microspheres: formulation considerations and in vitro/in vivo evaluation. Int J Pharm 195:179-188.